Cold‐water vibriosis. The current status of knowledge

• Published in: Journal of Fish Diseases
• Main Authors: Kashulin, A, Seredkina, N, Sørum, H
• Format: Article in Journal/Newspaper
• Language: English
• Published: Wiley 2016
• Subjects: Atlantic salmon
• Online Access: http://dx.doi.org/10.1111/jfd.12465; https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjfd.12465; https://onlinelibrary.wiley.com/doi/pdf/10.1111/jfd.12465

Abstract The current review for the first time summarizes the findings of the 30 years of research on cold‐water vibriosis ( CWV ). The diseased caused by Aliivibrio salmonicida (earlier known as Vibrio salmonicida ) was for the first time described in 1986 and became one of the most important bacterial diseases in salmon aquaculture. The lack of appropriate vaccine hampered development of Atlantic salmon aquaculture until the late 1980s when a novel vaccine allowed dramatic increase in the Atlantic salmon farming. In December 2007, the genus Vibrio was split into two genera and several bacterial species including V. salmonicida were transferred to genus Aliivibrio . The change of the names create significant difficulties with the designation of the CWV disease agent since its abbreviation A. salmonicida became similar to another well‐known salmon pathogen Aeromonas salmonicida ( A. salmonicida ). The disease was considered as controlled by vaccination, but reappeared at Atlantic salmon farms in 2011, this time affecting vaccinated Atlantic salmon. The current review summarizes the knowledge on pathogenesis, vaccination and treatment of CWV and proposes further directions for studying the disease.